Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Homeostasis in Sarcoidosis
NCT03621553Phase 4Recruiting
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2010
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of vitamin d in sarcoidosis and Vitamin D deficiency (VDD) (3 arms), sponsored by UT Southwestern Medical Center. Primary endpoint: Change in lung function at 24 weeks. Started Jul 2010; status: recruiting.
02
Drugs
vitamin d
03
Conditions
sarcoidosisVitamin D deficiency (VDD)
Beyond the preview
Go deeper on NCT03621553.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03621553.